FDA Clearance Tracker · P040037-S007
GORE VIABAHN ENDOPROSTHESIS
Last checked: Nov 20, 2026Latest source record: Aug 14, 2008 (this decision)Source: openFDAMethods & limitations
Decided
Aug 14, 2008
Approved
Time to decision
268 days
Received Nov 20, 2007. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P040037-S007
- Device name
- GORE VIABAHN ENDOPROSTHESIS
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Nov 20, 2007
- Decided
- Aug 14, 2008
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P040037
Device type
- Device type
- STENT, SUPERFICIAL FEMORAL ARTERY (NIP)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
APPROVAL OF AN EXTENSION OF THE INDICATIONS FOR USE TO INCLUDE ILIAC ARTERIAL LESIONS. THE DEVICE IS INDICATED FOR IMPROVING BLOOD FLOW IN PATIENTS WITH SYMPTOMATIC PERIPHERAL ARTERIAL DISEASE IN ILIAC ARTERY LESIONS WITH REFERENCE VESSEL DIAMETERS RANGING FROM 4.0-12.0 MM.
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.